Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Taysha Gene Therapies Inc (NQ: TSHA ) 2.300 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Taysha Gene Therapies Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Taysha Gene Therapies to Participate in Upcoming Investor Healthcare Conference and CEO Forum June 15, 2021 From Taysha Gene Therapies, Inc. Via Business Wire Taysha Gene Therapies to Host First Annual Stockholder Meeting June 10, 2021 From Taysha Gene Therapies, Inc. Via Business Wire Expert Ratings for Taysha Gene Therapies June 09, 2021 Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 1 0... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2021 June 09, 2021 Upgrades According to Deutsche Bank, the prior rating for KLA Corp (NASDAQ:KLAC) was changed from Hold to Buy. KLA earned $3.85 in the third quarter, compared to $2.47 in... Via Benzinga Earnings Scheduled For May 11, 2021 May 11, 2021 Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2021 June 08, 2021 Upgrades According to Seaport Global, the prior rating for CMC Materials Inc (NASDAQ:CCMP) was changed from Neutral to Buy. CMC Materials earned $1.71 in the second... Via Benzinga Taysha Gene Therapies to Participate in Upcoming June Investor Healthcare Conferences May 26, 2021 From Taysha Gene Therapies, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For May 19, 2021 May 19, 2021 Upgrades For Agilysys Inc (NASDAQ:AGYS), Craig-Hallum upgraded the previous rating of Hold to Buy. Agilysys earned $0.21 in the fourth quarter, compared to $0.05 in the... Via Benzinga Taysha Gene Therapies Joins the Rare Disease Company Coalition May 19, 2021 From Taysha Gene Therapies, Inc. Via Business Wire Taysha Gene Therapies Expands Leadership Team with the Appointment of Chief Development Officer May 13, 2021 From Taysha Gene Therapies, Inc. Via Business Wire Taysha Gene Therapies to Participate in Upcoming May Investor Healthcare Conferences May 12, 2021 From Taysha Gene Therapies, Inc. Via Business Wire Why Taysha Gene Therapies's Stock is Trading Higher Today April 12, 2021 The Price And Volume Action In Taysha Gene Therapies's Stock Today Taysha Gene Therapies's (NASDAQ: Via Benzinga Taysha Gene Therapies, Inc. (TSHA) Q1 2021 Earnings Call Transcript May 11, 2021 TSHA earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update May 11, 2021 From Taysha Gene Therapies, Inc. Via Business Wire Taysha Gene Therapies' Rett Syndrome Candidate Shows Encouraging Action In Animal Studies, Human Trial To Start By 2021 May 10, 2021 Taysha Gene Therapies Inc (NASDAQ: TSHA) has announced the online publication of new preclinical data for TSHA-102 in Rett syndrome. The data will be included in... Via Benzinga Taysha Gene Therapies Announces Publication of Preclinical Data for TSHA-102 in Rett Syndrome in Brain, a Highly Esteemed Neurological Science Peer-Reviewed Journal May 10, 2021 From Taysha Gene Therapies, Inc. Via Business Wire The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings May 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... Via Benzinga Exposures COVID-19 Product Safety The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings May 09, 2021 Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... Via Benzinga Exposures COVID-19 Product Safety Taysha Gene Therapies Announces Multiple Data Presentations and Workshop Presentations at the 24th Annual Meeting of the American Society of Gene & Cell Therapy May 05, 2021 From Taysha Gene Therapies, Inc. Via Business Wire Taysha Gene Therapies to Release First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11 May 04, 2021 From Taysha Gene Therapies, Inc. Via Business Wire Taysha Gene Therapies Announces New Data on Multiple Preclinical Programs and Upcoming R&D Day April 14, 2021 From Taysha Gene Therapies, Inc. Via Business Wire 55 Biggest Movers From Yesterday April 13, 2021 Gainers Celcuity Inc. (NASDAQ: CELC) jumped 29.4% to settle at $27.94. Celcuity shares climbed 51% on Friday after the company announced a worldwide licensing agreement with... Via Benzinga What's Going On With MOSY Stock And TSHA Stock? April 12, 2021 MoSys Inc. (NASDAQ: MOSY) shares are trading higher after the company announced it has expanded its patent portfolio through the purchase of five patents in the area of search and... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Mid-Afternoon Market Update: Dow Falls Over 100 Points; Canaan Shares Tumble After Q4 Results April 12, 2021 Toward the end of trading Monday, the Dow traded down 0.32% to 33,691.74while the NASDAQ fell 0.52% to 13,828.15. The S&P also fell, dropping 0.20% to 4,120.43. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Intraday Session April 12, 2021 Gainers 180 Life Sciences (NASDAQ:ATNF) shares increased by 27.31% to $12.4 during Monday's regular session. Trading volume for 180 Life Sciences's stock is 29.3... Via Benzinga Mid-Day Market Update: Crude Oil Rises 2%; iRhythm Technologies Shares Plummet April 12, 2021 Midway through trading Monday, the Dow traded down 0.22% to 33,725.47 while the NASDAQ fell 0.55% to 13,823.65. The S&P also fell, dropping 0.21% to 4,120.15. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 42 Stocks Moving In Monday's Mid-Day Session April 12, 2021 Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that Modell's Sporting Goods had reported a stake... Via Benzinga Taysha Gene Therapies Stock Is Trading Higher After Buying Rights To New Gene Therapy Candidate For Neurodegenerative Disease April 12, 2021 Taysha Gene Therapies Inc (NASDAQ: TSHA) has unveiled a deal for global rights to the AAV9 gene therapy program, now known as TSHA-120, to treat giant axonal... Via Benzinga Taysha Gene Therapies Acquires Exclusive Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program, Now Known as TSHA-120, for the Treatment of Giant Axonal Neuropathy, a Rare and Severe Neurodegenerative Disease April 12, 2021 From Taysha Gene Therapies, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.